Peer-reviewed veterinary case report
Adiponectin receptor agonist reduces broiler hepatic lipid deposition.
- Journal:
- Frontiers in veterinary science
- Year:
- 2025
- Authors:
- Tan, Wenhao et al.
- Affiliation:
- College of Veterinary Medicine · China
Abstract
To investigate the effects of AdipoRon on fatty liver syndrome (FLS) in chicken, we used a corticosterone (CORT)-induced fatty liver model in Cobb broilersand fat emulsion-induced model in Leghorn male hepatoma cells (LMH). In thestudy, eighteen 33-day-old male Cobb broilers were randomly assigned to three groups: control group (CONT, vehicle), corticosterone-treated group (CORT, 4 mg/kg), and corticosterone with AdipoRon-treated group (CORT-AR, 4 mg/kg and 0.2 mg/kg, 1 time/1 day) for 5 days. The results showed AdipoRon reduced CORT-induced increase in liver crude fat content ( < 0.05), increased protein expressions of peroxisome proliferator-activated receptor(PPARα) ( < 0.05) and adiponectin (ADPN) ( < 0.05), and suppressed the protein expressions of Acetyl-CoA carboxylase 1 (ACC) ( < 0.05) and phosphorylated c-Jun N-terminal kinase 1 (p-JNK1) ( < 0.05) in the liver. In thestudy, LMH cells were divided into control (CN), fat emulsion (FE, 10%), and FE + AdipoRon (4 μM) group (FE-AR). AdipoRon reduced FE-induced lipid accumulation ( < 0.05), decreased the protein expression of ACC and tumor necrosis factor-alpha (TNF-), and enhanced PPARα, the phosphorylation of adenosine 5'-monophosphate-activated protein kinase (AMPK), and carnitine palmitoyl transferase 1 (CPT-1) ( < 0.05). In conclusion, AdipoRon effectively reduces hepatic lipid deposition in CORT-induced FLS broilers, likely through PPARα activation and inhibition of lipid synthesis via ACC downregulation.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/41049148/